| Literature DB >> 16301272 |
Thouraya Chabbouh1, Claude Lentschener, Mathieu Zuber, Nicole Jude, Bernard Delaitre, Yves Ozier.
Abstract
We diagnosed cauda equina syndrome 15 h after uneventful single spinal administration of 0.5% hyperbaric bupivacaine 12.5 mg through a 27-gauge pencil-point type needle. No preexisting neurologic disorder was recorded. There was no pain or paresthesia during needle placement or drug injection. The sensory levels were bilateral, symmetric, and caudal to T8. Resolution of most of the symptoms occurred within a few days but some foot drop persisted for 2 yr after the procedure. Bupivacaine neurotoxicity is suggested by the absence of any other identifiable cause for this neurologic deficit.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16301272 DOI: 10.1213/01.ANE.0000184126.57327.C3
Source DB: PubMed Journal: Anesth Analg ISSN: 0003-2999 Impact factor: 5.108